SCHEMBL1422378

SCHEMBL1422378

Cc1cc(-c2cccc(C(F)(F)F)c2)c(C(=O)OCC(N)=O)nc1C(=O)N1CCC(N2CCCC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.41
TRPV4 Q9HBA0 9/20 0.40
ACACB O00763 1/20 0.39
ACACA Q13085 1/20 0.39
TACR2 P21452 1/20 0.39
TACR3 P29371 1/20 0.39
KCNH2 Q12809 1/20 0.39
CACNA1C Q13936 1/20 0.39
SCN5A Q14524 1/20 0.39
L3MBTL3 Q96JM7 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
GRIN2B Q13224 1/20 0.38
CALCA P06881 1/20 0.38
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1422177 0.89 IRAK4 (0.44) IRAK4TRPV4ACACBACACATACR2
SCHEMBL1422418 0.89 IRAK4 (0.43) IRAK4TRPV4ACACBACACATACR2
SCHEMBL1422960 0.86 L3MBTL3 (0.45) IRAK4TRPV4ACACBACACATACR2
SCHEMBL1420845 0.84 IRAK4 (0.44) IRAK4TRPV4ACACBACACATACR2
SCHEMBL1422325 0.84 L3MBTL3 (0.49) IRAK4TRPV4ACACBACACATACR2
SCHEMBL1422216 0.84 ACACB (0.43) IRAK4TRPV4ACACBACACATACR2
SCHEMBL1421156 0.83 IRAK4 (0.45) IRAK4TRPV4ACACBACACATACR2
SCHEMBL1421088 0.83 IRAK4 (0.45) IRAK4TRPV4ACACBACACATACR2
SCHEMBL1421240 0.83 IRAK4 (0.43) IRAK4TRPV4ACACBACACATACR2
SCHEMBL1421257 0.83 IRAK4 (0.44) IRAK4TRPV4ACACBACACATACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2297137-A1 NOVEL HETEROARYL CARBOXAMIDE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2011-03-23 EP disclosed